You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Exercise Disclosure
Janku Filip · SEC Form 4 · Filed Jul 1, 2026
Exercise
Calculated transaction value
$72.51K
Janku Filip Chief Medical Officer
GLUE
Transaction date
Jun 30, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$24.2
Jun 30, 2026
First close after public filing
$24.21
Jul 2, 2026
30-day return after filing
-31.76%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,407 shares @ $13.41
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-292767
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$204.98K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE Current | Exercise | Jun 30, 2026 | $72.51K |
| Monte Rosa Therapeutics, Inc. GLUE | Sale | Jun 30, 2026 | $132.47K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 30, 2026 | $0 |